Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · IEX Real-Time Price · USD
2.000
-0.120 (-5.66%)
Jul 2, 2024, 3:59 PM EDT - Market closed
Immix Biopharma Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Immix Biopharma stock have an average target of 10.5, with a low estimate of 7.00 and a high estimate of 14. The average target predicts an increase of 425.00% from the current stock price of 2.00.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for IMMX stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 2 |
Buy | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +250.00% | Jul 1, 2024 |
Roth MKM | Roth MKM | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +600.00% | Aug 14, 2023 |
Roth MKM | Roth MKM | Strong Buy Initiates $14 | Strong Buy | Initiates | $14 | +600.00% | Feb 22, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.95
from -0.89
EPS Next Year
-1.03
from -0.95
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | n/a | 12.7M | 50.6M | 115.4M |
Avg | n/a | n/a | 12.4M | 49.1M | 112.1M |
Low | n/a | n/a | 11.9M | 47.2M | 107.7M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | 308.3% | 134.9% |
Avg | - | - | - | 296.6% | 128.2% |
Low | - | - | - | 281.1% | 119.2% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -0.98 | -1.06 | -0.39 | 0.87 | 2.87 |
Avg | -0.95 | -1.03 | -0.38 | 0.85 | 2.78 |
Low | -0.91 | -0.99 | -0.36 | 0.81 | 2.68 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | 238.6% |
Avg | - | - | - | - | 228.9% |
Low | - | - | - | - | 216.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.